MDS Virtual Congress 2020 » Parkinsonism, Others

Apomorphine as a Diagnostic tool to Identify Levodopa Responsive Atypical Parkinsonism

M. Faisal, D. Sreenivasa, R. Jayachandran, R. Seetharam, R. Iyer, P. Kukkle (Bengaluru, India)

Association between Glutamic Acid Decarboxylase Antibodies (Anti-GADs) and Parkinsonism: Case Report

W. Trillo Alvarez, J. Molina Acosta, J. Medina Suarez, A. Escalante Mercado, M. Torres Medina, E. Carrillo Monteagudo, G. Calderon Paiva, J. Valdivia Pinto, M. Mejia Vega (Arequipa, Peru)

Atypical parkinsonism due to a mutation in the SLC9A6 gene

L. Muñoz-Delgado, S. Jesús, D. Macías-García, A.D Adarmes-Gómez, F. Pérez-Errazquin, F. Carrillo, P. Mir (Seville, Spain)

Burden of Care-Partners of People with Parkinson’s Disease: Findings from Parkinson’s Disease Real-World Impact Assessment (PRISM) Study

E. Tolosa, J. Ferreira, A. Antonini, A. Lees, T. Foltynie, G. Ebersbach, O. Rascol, J.F Rocha, D. Magalhães, P. Soares-da-Silva (Barcelona, Spain)

Clinical and neurological features of the course of parkinsonism in the presence of chronic renal disease

S. Khudayarova, G. Rakhmatullaeva (Tashkent, Uzbekistan)

Clinical and nuclear neuroimaging features of Parkinson’s disease with dysphagia

K. Ohta, T. Nakajima (Kashiwazaki city Niigata, Japan)

Development and validation of a profile of peripheral immune biomarkers for Parkinson’s disease: A multicenter, retrospective study

Y. Li, J. Liu (Shanghai, China)

Intracranial Tuberculous Abcess with Acute Parkinsonism: Unusual Finding

KK. Shahedah, A.A Nurul Asyikin (Kuala Lumpur, Malaysia)

Long and short survival in Parkinson syndrome: pathology and genetics are key prognostic factors

A. Rajput, C. Robinson, M. Farrer, E. Gustavsson, A. Rajput (Saskatoon, SK, Canada)

May Safinamide have a Role in Atypical Parkinsonism? A Retrospective Study in Clinical Practice

F. Rodríguez Jorge, A. Beltrán Corbellini, J.L Chico García, P. Parra Díaz, P. Pérez Torre, B. Baena Álvarez, I. Parées Moreno, J.L López-Sendón, J.C Martínez Castrillo, A. Alonso Cánovas, S. Fanjul Arbós (Madrid, Spain)

Microbiome from Parkinson’s patients shows an increase in polyamines metabolism and differentially expresses microbial bacterial taxa compared to aged-matched normal controls

S. Melgar, N. Danso, C. Pena, J. Ahmed, S. Kumar, R. Kumar, C. Carlin, D. Linseman, D. Paredes (Denver, CO, USA)

Parkinsonism secondary to mercury poisoning in a Colombian population

J. Vargas (Bogotá, Colombia)

Parkinsonism, delayed chorea and dystonia caused by extrapontine myelinolysis

N.A Gandarilla Martínez, H.R Martínez Hernández (Mexico City, Mexico)

Patient Characteristics, Treatment Patterns and Disease Burden in People with Parkinson’s Disease: Insights from the Parkinson’s Disease Real-World Impact Assessment (PRISM) Study

T. Foltynie, E. Tolosa, J. Ferreira, A. Antonini, A. Lees, G. Ebersbach, O. Rascol, J.F Rocha, D. Magalhães, P. Soares-da-Silva (London, United Kingdom)

Personal Kinetigraph and Deep Brain Stimulation with Parkinson’s Disease

A. Potter, G. Newsome, G. Kern, A. Parsons, D. Page, Y. Dalati, C. Sidiropoulos MD (East Lansing, MI, USA)

Potential Diagnosis Biomarks in Serum Biochemical items of Vascular Parkinsonism Patients

Y. Li, YY. Gao, K. Nie, L.J Wang (Guangzhou, China)

Risk Factors and Subtypes of Ischemic Stroke in Patients with Parkinson’s Disease

M. Burzhunova, N. Garabova (Moscow, Russian Federation)

Serum neurofilament light chain differentiates early Parkinson’s disease from progressive supranuclear palsy-parkinsonism

R. Yadav, P. Ramaswamy, P. Pal, R. Christopher (Bengaluru, India)

Socio-economic determinants of diagnostic latency in Parkinson’s disease patients

P. Surathi, E. Feinstein (Newark, NJ, USA)

Staircase sign for Atypical and Secondary parkinsonism

Y.S Oh, J.S Kim, D.Y Kwon, M.H Park, B.R Bloem (Seoul, Republic of Korea)

Temporhythmal Correction: The New Way of Therapy and Diagnostic Secondary Vascular Parkinsonism

D.T Akramova (Tashkent, Uzbekistan)

The effect of comorbid NPH on the clinical feature and progression of Parkinson’s disease

A. Hattori, T. Tsunemi, Y. Ishiguro, N. Hattori (Tokyo, Japan)

Use of Figurative Language in Describing OFF Periods in Parkinson’s Disease

B. Edison, S. Mantri, M. Daeschler, C. Kopil, C. Marras, S. Kahl, L. Chahine (Pittsburgh, PA, USA)

Vascular Parkinsonism (VP) score: A clinical scoring system to differentiate between vascular from degenerative parkinsonism

M.I Acharya (Kolkata, India)

Vascular parkinsonism and Parkinson’s disease: Differences concerning performance in activities of daily living

R. Jesus, R. Raimundo, A. Marques, C. Azoia, M. Mendes, A. Velon (Vila Real, Portugal)